osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis
You'll hear more controversy about osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis.
This destruction of the jaw bone was initially seen in patients on high doses of IV bisphosphonates for cancer.
The incidence with ORAL bisphosphonates is much lower...probably less than 0.1%.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote